Clinical trials: HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
This study is a single center, non-interference, retrospective registration study: HER2 testing and disease information collection were conducted on patients diagnosed with prostate cancer and able to obtain tumor tissue in our…
- Trial name
- NCT06146114
- Testing
- Collect HER2 expression in prostate cancer patients
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Qilu Hospital of Shandong University